The government’s major drive to introduce high-tech DNA mapping for patients will start by tackling cancer, rare diseases and infectious diseases.
Search results for
728 results found
Businesses are being offered a share of £10 million to develop cutting edge technology to analyse and better interpret significant variations in the DNA of NHS patients with serious illnesses.
Patients with rare inherited diseases have started providing samples of their blood so the whole of their DNA can be sequenced by Genomics England.
Genomics England has been recognised as one of 2014’s 50 Smartest Companies in MIT Technology Review’s annual list of the world’s most innovative technology companies.
The UK is set to become the world leader in ground-breaking genetic research into cancer and rare diseases, which will transform how diseases are diagnosed and treated.
Genomics England, the company leading the UK’s 100,000 Genomes Project, has released details of those companies that distinguished themselves in its annotation assessment exercise.
Genomics England is today inviting applications to join our new Clinical Interpretation Partnership from UK researchers, NHS Clinicians and those in training.
NHS England has announced eleven Genomic Medicine Centres that will lead the way in delivering the 100,000 Genomes Project.
Genomics England Responds to President Obama’s Precision Medicine Initiative
Genomics England has announced today a partnership with the NIHR National Biosample Centre.
The first family are set to benefit from ground-breaking developments in whole genome sequencing.
Genomics England announced the successful companies in its Small Business Research Initiative (SBRI) Phase Two assessment of Enabling Technologies for Genomics Sequence Data Analysis &…
The 100,000 Genomes Project has now received ethical approval for the main phase of the programme.
The first patient was recruited to the main phase of the ground-breaking 100,000 Genomes Project this week.
Genomics England has today (26 March 2015) announced a new collaboration as part of the 100,000 Genomes Project, to accelerate the development of new diagnostics and treatments for patients.
The main phase of the 100,000 Genomes Project has now begun with 11 Genomic Medicine Centres announced in December 2014 and the first patients recruited in March.
Our partners at Health Education England (HEE) have recently confirmed the nine Universities across the UK that will deliver the new Masters in Genomic Medicine.
Genomics England has today announced the four companies it has chosen to explore working with on the interpretation of the genomes of the first 8,000 patients in the 100000 Genomes Project.
Last week (11th June) we launched our seminar series in Genomic Medicine. The first speaker was Professor Madhuri Hegde from Emory University, USA.
Genomics England has today (19th June) confirmed which researchers will work on data from the 100,000 Genomes Project, and what topics and disease areas they will be working on.